-
Eur. J. Heart Fail. · Mar 2000
ReviewIntravenous inotropic agents in the intensive therapy unit: do they really make a difference?
- C Opasich, A Russo, R Mingrone, M Zambelli, and L Tavazzi.
- S. Maugeri Foundation, Institute of Care and Scientific Research, Cardiology Division, Medical Center of Pavia, 27100, Pavia, Italy. copasich@fsm.it
- Eur. J. Heart Fail. 2000 Mar 1; 2 (1): 7-11.
AbstractPart of the management of refractory heart failure is treatment aimed at preventing organ damage due to inadequate oxygen delivery, improving hemodynamics, and maximizing cardiac output while maintaining only mildly elevated ventricular filling pressures The aim of this paper is to review the most updated indications on intravenous inotropic agents, and to compare their cardiac and peripheral effects. Finally, clinical implications of their use (alone or in combination) are reviewed.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..